Michael Decker
Michael Decker has studied chemistry at University of Bonn, Germany, and Cambridge, UK. After his PhD in Medicinal Chemistry at Bonn University on dopamine receptor ligands, he worked in a company. After that, he obtained his teaching qualification (“habilitation”) in Pharmacy from University of Jena, Germany. He was Visiting Scientist at McLean Hospital, Harvard Medical School, and lecturer for Medicinal Chemistry at Queen’s University Belfast, UK, before he was appointed Professor for Pharmaceutical/Medicinal Chemistry at Würzburg University, Germany. His research interests are focused on Chemical Neuroscience, dealing with the development of PET ligands for diagnostics of cardiac diseases and neuroinflammation, hybrid molecules against Alzheimer’s disease, natural products’ neuroprotective properties and photopharmacology.
Recent Comments